Mizizi Africa Homes has clinched the 2020 Real Estate Excellence Award for the best low-cost housing developer in Kenya.
In a statement issued on Monday, Mizizi Africa Homes Chief Executive Officer George Mburu said the award is reflective of the firm’s commitment and dedication to providing high-quality, decent, and affordable housing solutions in line with the government’s Big 4 Agenda Housing Pillar.
“We are very pleased to receive this recognition of our efforts especially in a tough year that we strived to deliver our maiden project within deadline amid the COVID-19 p******c and launched additional projects that customers have shown tremendous interest in,” said Mburu.
The developer handed over its first project, Penguin Estate in October, and will by end of January 2021 it will be handing over its second project, Heritage Phase 1, currently 80 percent complete.
He added, “From the most promising developer in similar awards during the 2nd Annual Real Estate Excellence Awards in 2019 to the first position shows how we have significantly grown to be a trusted brand in delivery of affordable housing to Kenyans.”
Megaprojects launched by the firm in 2020 have advanced and modern features consisting of extra private room that can be used as a library or office, and spacious parking area at very competitive rates.
They include Peacock Phase 1 which has been sold out that comprises seven maisonettes and 21 bungalows, Peacock phase 2, a mix of bungalows and maisonettes, and comprises 28 units. Heritage phase 2 and Pigeon estates.
“As we move to the next year, we are looking into even robust partnerships to introduce better affordable financial solutions as part of our strategy to ease and see more Kenyans own their dream homes,” said Mburu.
The Real Estate Excellence Awards now in its third year, recognizes and celebrates key players in the real estate sector who have over the years achieved excellent results and have positively impacted the lives of their clients.
This year’s award gala event was withheld due to COVID-19 restrictions.